IDE and Alzheimer disease: The insulin-degrading enzyme (IDE)—which plays an important role in the degradation of amyloid beta (Aβ) monomers [108], and is reduced in AD brains [109]—is competitively inhibited by insulin, leading to the elevation of extracellular Aβ levels [110].